L3VLUP
ProSign in

ZBH · LLY in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

ZBHLLY
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • ZBH
  • LLY
0204060202120222023202420252026
Holders and value by quarter
QuarterZBHLLY
Q3 202021 holders, $5.3bn33 holders, $14.1bn
Q4 202022 holders, $6.0bn29 holders, $17.3bn
Q1 202122 holders, $5.5bn24 holders, $23.0bn
Q2 202123 holders, $5.6bn24 holders, $27.8bn
Q3 202123 holders, $4.4bn31 holders, $29.9bn
Q4 202120 holders, $3.4bn31 holders, $34.7bn
Q1 202217 holders, $3.4bn24 holders, $35.3bn
Q2 202216 holders, $3.1bn33 holders, $42.7bn
Q3 202219 holders, $3.7bn31 holders, $43.4bn
Q4 202220 holders, $4.6bn31 holders, $46.6bn
Q1 202326 holders, $4.7bn33 holders, $44.3bn
Q2 202323 holders, $5.1bn37 holders, $59.6bn
Q3 202327 holders, $4.0bn44 holders, $67.6bn
Q4 202321 holders, $4.3bn45 holders, $73.6bn
Q1 202419 holders, $5.7bn41 holders, $95.3bn
Q2 202417 holders, $4.5bn43 holders, $110bn
Q3 202415 holders, $4.3bn45 holders, $107bn
Q4 202417 holders, $4.8bn46 holders, $93.9bn
Q1 202517 holders, $5.1bn42 holders, $98.4bn
Q2 202512 holders, $4.5bn43 holders, $93.2bn
Q3 202512 holders, $4.9bn39 holders, $86.7bn
Q4 20258 holders, $4.9bn41 holders, $123bn
Q1 20268 holders, $4.2bn39 holders, $106bn
Q2 202612 holders, $4.3bn44 holders, $132bn
ZBH

Zimmer Biomet Holdings Inc

Holders
12
Reported value
$4.9bn
Buyers
5
Sellers
7

Breadth -2 among 95 comparable managers.

Medical devices and instrumentsHealthcare: biopharma and medtech · L3VLUPSurgical, medical and electromedical devices
LLY

Eli Lilly & Co

Holders
39
Reported value
$86.7bn
Buyers
22
Sellers
22

Breadth 0 among 95 comparable managers.

Pharmaceuticals and biotechnologyHealthcare: biopharma and medtech · L3VLUPPharmaceutical preparations

Who holds both, Q3 2025

Among the 41 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Only ZBH (2)

First Eagle Investment Management LLC, Moore Capital Management LP

Only LLY (29)

Acadian Asset Management LLC, AllianceBernstein LP, Artisan Partners LP, Balyasny Asset Management LLC, Brevan Howard Capital Management LP, Bridgewater Associates LP, Capital Research Global Investors, Capital World Investors, Caxton Associates LLP, Citadel Advisors LLC, D. E. Shaw & Co., Eisler Capital Management Ltd, Fidelity (FMR LLC), Holocene Advisors LP, Hudson Bay Capital Management LP, Jane Street Group LLC, Janus Henderson Group Ltd, Man Group PLC, Millennium Management LLC, Neuberger Berman Group LLC, Polen Capital Management LLC, Schonfeld Strategic Advisors LLC, Squarepoint Ops LLC, Two Sigma Advisers LP, Two Sigma Investments LP, and 4 more

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →